Cardiac contractility modulation (CCM) is an innovative device-based therapy designed to enhance myocardial performance in patients with heart failure, particularly those with reduced ejection ...
Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...
Please provide your email address to receive an email when new articles are posted on . The Integra-D trial evaluated a novel implantable cardiac contractility modulation defibrillator for its ability ...
MINNEAPOLIS — Switching candidates for implantable cardioverter-defibrillator (ICD) implantation to a dual-function device that also modulates cardiac contractility was associated with successful ...
MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
The American Medical Association’s CPT editorial panel will meet May 1-3 to consider codes for several devices and services, but the most important of these might be the code for cardiac contractility ...
The heart is under continuous control by the autonomic nervous system, in which sympathetic and parasympathetic branches exert opposing influences on rate, rhythm and contractility. In health, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results